K. Zint, W. Haefeli, R. Glynn, H. Mogun, J. Avorn et al., Impact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adults, Pharmacoepidemiology and Drug Safety, vol.53, issue.12, pp.1248-55, 2010.
DOI : 10.1002/pds.2031

C. Wu, T. Ting, S. Wang, I. Chang, and K. Lin, Effect of Benzodiazepine Discontinuation on Dementia Risk, The American Journal of Geriatric Psychiatry, vol.19, issue.2, pp.151-160, 2011.
DOI : 10.1097/JGP.0b013e3181e049ca

B. Hemmelgarn, S. Suissa, A. Huang, J. Boivin, and G. Pinard, Benzodiazepine Use and the Risk of Motor Vehicle Crash in the Elderly, JAMA: The Journal of the American Medical Association, vol.278, issue.1, pp.27-31, 1997.
DOI : 10.1001/jama.1997.03550010041037

H. Guide, A. Parr, J. Kavanagh, D. Young, R. Mccafferty et al., Available from: http://www.hassante .fr/portail/jcms/c_556899/en/ald-n-23-guide-medecin-sur-les-troubles-anxieux-graves 6 Views of general practitioners and benzodiazepine users on benzodiazepines: A qualitative analysis, Soc Sci Med, vol.62, issue.5, pp.1237-1286, 2006.

A. Siriwardena, Z. Qureshi, S. Gibson, S. Collier, and M. Latham, GPs' attitudes to benzodiazepine and " Z-drug " prescribing: a barrier to implementation of evidence and guidance on hypnotics, Br J Gen Pract, vol.56, issue.533, pp.964-971, 2006.

S. Billioti-de-gage, B. Bégaud, F. Bazin, H. Verdoux, J. Dartigues et al., Benzodiazepine use and risk of dementia: prospective population based study, BMJ, vol.345, issue.sep27 4, p.6231, 2012.
DOI : 10.1136/bmj.e6231

A. Holbrook, R. Crowther, A. Lotter, C. Cheng, and D. King, Meta-analysis of benzodiazepine use in the treatment of insomnia, Can Med Assoc J, vol.162, issue.2, pp.225-258, 2000.

C. Vinkers and B. Olivier, Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators?, Advances in Pharmacological Sciences, vol.57, issue.2, p.416864, 2012.
DOI : 10.1016/S0376-8716(00)00123-X

J. Glass, K. Lanctôt, N. Herrmann, B. Sproule, and U. Busto, Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits, BMJ, vol.331, issue.7526, p.1169, 2005.
DOI : 10.1136/bmj.38623.768588.47

A. Lasserre, N. Younes, T. Blanchon, I. Cantegreil-kallen, C. Passerieux et al., Psychotropic drug use among older people in general practice: discrepancies between opinion and practice, British Journal of General Practice, vol.60, issue.573, pp.156-62, 2010.
DOI : 10.3399/bjgp10X483922

A. Siriwardena, T. Apekey, M. Tilling, J. Dyas, H. Middleton et al., General practitioners' preferences for managing insomnia and opportunities for reducing hypnotic prescribing, Journal of Evaluation in Clinical Practice, vol.28, issue.10, pp.731-738, 2010.
DOI : 10.1111/j.1365-2753.2009.01186.x

URL : http://eprints.lincoln.ac.uk/3187/

H. Ashton, The diagnosis and management of benzodiazepine dependence, Current Opinion in Psychiatry, vol.18, issue.3, pp.249-55, 2005.
DOI : 10.1097/01.yco.0000165594.60434.84

. Briot, Rapport sur le bon usage des médicaments psychotropes Assemblée Nationale. [Internet], 2006.

S. Soumerai, L. Simoni-wastila, C. Singer, C. Mah, X. Gao et al., Lack of Relationship Between Long-Term Use of Benzodiazepines and Escalation to High Dosages, Psychiatric Services, vol.54, issue.7, pp.1006-1017, 2003.
DOI : 10.1176/appi.ps.54.7.1006

M. Olfson, M. King, and M. Schoenbaum, Benzodiazepine Use in the United States, JAMA Psychiatry, vol.72, issue.2, pp.136-178
DOI : 10.1001/jamapsychiatry.2014.1763

N. Lechevallier, A. Fourrier, and C. Berr, Benzodiazepine use in the elderly: the EVA Study]. Rev D'Epidémiologie Santé Publique, pp.317-343, 2003.

J. Cook, R. Marshall, C. Masci, and J. Coyne, Physicians??? Perspectives on Prescribing Benzodiazepines for Older Adults: A Qualitative Study, Journal of General Internal Medicine, vol.1, issue.4, pp.303-310, 2007.
DOI : 10.1007/s11606-006-0021-3

C. Sirdifield, S. Anthierens, H. Creupelandt, S. Chipchase, T. Christiaens et al., General practitioners??? experiences and perceptions of benzodiazepine prescribing: systematic review and meta-synthesis, BMC Family Practice, vol.7, issue.1, p.191, 2013.
DOI : 10.3109/13561829309014957

G. Pérodeau, É. Grenon, S. Grenier, O. Connor, and K. , Systemic model of chronic benzodiazepine use among mature adults, Aging & Mental Health, vol.66, issue.2, pp.1-11, 2009.
DOI : 10.1177/1533210110387687

C. Rat, G. Penhouet, A. Gaultier, A. Chaslerie, J. Pivette et al., Did the new French pay-for-performance system modify benzodiazepine prescribing practices?, BMC Health Services Research, vol.345, issue.Suppl 1, p.301, 2014.
DOI : 10.1136/bmj.e7500

URL : https://hal.archives-ouvertes.fr/inserm-01072525

C. Supérieur-de and L. Santé, L'impact des psychotropes sur la santé, avec une attention particulière pour les personnes âgées [Internet] Available from: http://health.belgium.be/internet2Prd/groups, 2011.

J. Hoebert, P. Souverein, A. Mantel-teeuwisse, H. Leufkens, and L. Van-dijk, Reimbursement Restriction and Moderate Decrease in Benzodiazepine Use in General Practice, The Annals of Family Medicine, vol.10, issue.1, pp.42-51, 2012.
DOI : 10.1370/afm.1319

B. Kollen, W. Van-der-veen, F. Groenhof, G. Donker, and K. Van-der-meer, Discontinuation of reimbursement of benzodiazepines in the Netherlands: does it make a difference?, BMC Family Practice, vol.266, issue.17, p.111, 2012.
DOI : 10.1001/jama.1991.03470170080028

K. Morgan, S. Dixon, N. Mathers, J. Thompson, and M. Tomeny, Psychological treatment for insomnia in the management of long-term hypnotic drug use: a pragmatic randomised controlled trial, Br J Gen Pract, vol.53, issue.497, pp.923-931, 2003.

B. Sivertsen, S. Omvik, and S. Pallesen, Cognitive Behavioral Therapy vs Zopiclone for Treatment of Chronic Primary Insomnia in Older Adults, JAMA, vol.295, issue.24, pp.2851-2859, 2006.
DOI : 10.1001/jama.295.24.2851